Literature DB >> 12148598

Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.

Ozden Sanal1, Fúgen Ersoy, Ilhan Tezcan, Ayşe Metin, Leman Yel, Gaël Ménasché, Aytemiz Gürgey, Izzet Berkel, Geneviève de Saint Basile.   

Abstract

Griscelli disease is a rare autosomal recessive disorder characterized by diffuse pigmentary dilution and occurrence of acute phases of uncontrolled lymphocyte and macrophage activation, so-called "hemophagocytic syndrome" (HS) that leads to death. Recently, two closely linked genes located on human 15q21 region have been found to be responsible for the disease. We present clinical and laboratory findings of 13 unrelated patients with Griscelli disease as well as mutation analyses in an effort to define a genotype-phenotype correlation. Eight patients who showed RAB27A mutations presented with HS. In contrast, two patients who primarily presented with a neurological impairment in the absence of infection susceptibility or HS were found to have homozygous MYO5A mutations. No mutation in RAB27A could be detected in the other three patients. One of the latter developed HS at a rather late age, while the other two are free of HS at 12 and 15 years of age. Griscelli disease presents with a heterogeneous clinical picture that seems to reflect the involved gene defect. This genotype-phenotype correlation suggests that the natural course of the disease and outcome is dictated by the site and type of the genetic mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12148598     DOI: 10.1023/a:1016045026204

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 2.  Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature.

Authors:  A J Mancini; L S Chan; A S Paller
Journal:  J Am Acad Dermatol       Date:  1998-02       Impact factor: 11.527

3.  Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice.

Authors:  L E Matesic; R Yip; A E Reuss; D A Swing; T N O'Sullivan; C F Fletcher; N G Copeland; N A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement.

Authors:  I Tezcan; O Sanal; F Ersoy; D Uckan; S Kiliç; A Metin; M Cetin; R Akin; C Oner; A Tuncer
Journal:  Bone Marrow Transplant       Date:  1999-10       Impact factor: 5.483

5.  Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.

Authors:  S Imashuku; S Hibi; T Ohara; A Iwai; M Sako; M Kato; H Arakawa; M Sotomatsu; S Kataoka; K Asami; D Hasegawa; Y Kosaka; K Sano; N Igarashi; K Maruhashi; R Ichimi; H Kawasaki; N Maeda; A Tanizawa; K Arai; T Abe; H Hisakawa; H Miyashita; J I Henter
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

6.  Partial albinism with immunodeficiency (Griscelli syndrome).

Authors:  C Klein; N Philippe; F Le Deist; S Fraitag; C Prost; A Durandy; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

7.  A kindred with Griscelli disease: spectrum of neurological involvement.

Authors:  H Hurvitz; R Gillis; S Klaus; A Klar; F Gross-Kieselstein; E Okon
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

8.  Griscelli syndrome: report of three cases.

Authors:  S Göğüş; M Topçu; T Küçükali; Z Akçören; I Berkel; F Ersoy; M Günay; I Saatçi
Journal:  Pediatr Pathol Lab Med       Date:  1995 Mar-Apr

9.  Mutations affecting pigmentation in man: I. Neuroectodermal melanolysosomal disease.

Authors:  B R Elejalde; J Holguin; A Valencia; E F Gilbert; J Molina; G Marin; L A Arango
Journal:  Am J Med Genet       Date:  1979

10.  Rab27a is required for regulated secretion in cytotoxic T lymphocytes.

Authors:  J C Stinchcombe; D C Barral; E H Mules; S Booth; A N Hume; L M Machesky; M C Seabra; G M Griffiths
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  19 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells.

Authors:  Maaike Neeft; Marnix Wieffer; Arjan S de Jong; Gabriela Negroiu; Corina H G Metz; Alexander van Loon; Janice Griffith; Jeroen Krijgsveld; Nico Wulffraat; Henriette Koch; Albert J R Heck; Nils Brose; Monique Kleijmeer; Peter van der Sluijs
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

Review 3.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

4.  Light microscopic examination of scalp hair samples as an aid in the diagnosis of paediatric disorders: retrospective review of more than 300 cases from a single centre.

Authors:  V V Smith; G Anderson; M Malone; N J Sebire
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

5.  Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.

Authors:  Setareh Mamishi; Mohammad Hossein Modarressi; Babak Pourakbari; Banafshe Tamizifar; Fatemeh Mahjoub; Alireza Fahimzad; Soheila Alyasin; Mohamad Hassan Bemanian; Amir Ali Hamidiyeh; Mohammad Reza Fazlollahi; Mahmoud Reza Ashrafi; Anna Isaeian; Ghamartaj Khotaei; Mehdi Yeganeh; Nima Parvaneh
Journal:  J Clin Immunol       Date:  2008-03-19       Impact factor: 8.317

6.  Mutation analysis and prenatal diagnosis of a family with Griscelli syndrome type 2: two novel mutations in the RAB27A gene.

Authors:  Patra Yeetong; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  World J Pediatr       Date:  2017-08       Impact factor: 2.764

7.  Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2.

Authors:  Lisa M Vincent; Fred Gilbert; Jennifer I DiPace; Carla Ciccone; Thomas C Markello; Andrew Jeong; Heidi Dorward; Wendy Westbroek; William A Gahl; James B Bussel; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2010-06-10       Impact factor: 4.797

Review 8.  Transplantation in rare lymphoproliferative and histiocytic disorders.

Authors:  Alexis Cruz-Chacon; John Mathews; Ernesto Ayala
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

9.  The actin-binding domain of Slac2-a/melanophilin is required for melanosome distribution in melanocytes.

Authors:  Taruho S Kuroda; Hiroyoshi Ariga; Mitsunori Fukuda
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Whole-genome SNP association in the horse: identification of a deletion in myosin Va responsible for Lavender Foal Syndrome.

Authors:  Samantha A Brooks; Nicole Gabreski; Donald Miller; Abra Brisbin; Helen E Brown; Cassandra Streeter; Jason Mezey; Deborah Cook; Douglas F Antczak
Journal:  PLoS Genet       Date:  2010-04-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.